Adenoid cystic carcinoma can be driven by MYB or MYBL1 rearrangements: New insights into MYB and tumor biology

Cancer Discovery

Volumn 6, Issue 2, 2016, Pages 125-127

  Gonda, Thomas J ^a   Ramsay, Robert G ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; NOTCH1 RECEPTOR; PROTEIN MYB; PROTEIN MYBL; UNCLASSIFIED DRUG; ONCOPROTEIN;

ADENOID CYSTIC CARCINOMA; ARTICLE; CELL CYCLE; DNA BINDING MOTIF; GENE FUSION; GENE REARRANGEMENT; GENE TRANSLOCATION; GENETIC TRANSFORMATION; GENOME; HUMAN; MYB GENE; MYBL GENE; NONHUMAN; ONCOGENE; PROTEIN EXPRESSION; GENETICS; ONCOGENE MYB;

CARCINOMA, ADENOID CYSTIC; GENES, MYB; HUMANS; ONCOGENE PROTEINS, FUSION; TRANSLOCATION, GENETIC;

EID: 84957070458     PISSN: 21598274     EISSN: 21598290     Source Type: Journal    
DOI: 10.1158/2159-8290.CD-15-1470     Document Type: Article

References (12)

1. Persson M, Andren Y, Mark J, Horlings HM, Persson F, Stenman G. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci U S A 2009; 106: 18740-4.
2. Wetterskog D, Lopez-Garcia MA, Lambros MB, A’Hern R, Geyer FC, Milanezi F, et al. Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers. J Pathol 2012; 226: 84-96.
3. Brayer KJ, Frerich CA, Kang H, Ness SA. Recurrent fusions in MYB and MYBL1 defi ne a common, transcription factor–driven oncogenic pathway in salivary gland adenoid cystic carcinoma. Cancer Discov 2016;6:176–87.
4. Mitani Y, Liu B, Rao PH, Borra VJ, Zafereo M, Weber RS, et al. Novel MYBL1 gene rearrangements with recurrent MYBL1–NFIB fusions in salivary adenoid cystic carcinomas lacking t(6;9) translocations. Clin Cancer Res 2016;22:725–33.
5. Ramsay RG, Gonda TJ. MYB function in normal and cancer cells. Nat Rev Cancer 2008; 8: 523-34.
6. Ramkissoon LA, Horowitz PM, Craig JM, Ramkissoon SH, Rich BE, Schumacher SE, et al. Genomic analysis of diffuse pediatric lowgrade gliomas identifi es recurrent oncogenic truncating rearrangements in the transcription factor MYBL1. Proc Natl Acad Sci U S A 2013; 110: 8188-93.
7. Lei W, Rushton JJ, Davis LM, Liu F, Ness SA. Positive and negative determinants of target gene specifi city in myb transcription factors. J Biol Chem 2004; 279: 29519-27.
8. Lipsick JS. One billion years of Myb. Oncogene 1996; 13: 223-35.
9. Yotam D, Cotton MJ, Williamson KE, Gillespie SM, Ryan RJH, Kluk MJ, et al. An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma. Nat Genet. In press.
10. Stephens PJ, Davies HR, Mitani Y, Van Loo P, Shlien A, Tarpey PS, et al. Whole exome sequencing of adenoid cystic carcinoma. J Clin Invest 2013; 123: 2965-8.
11. Cross RS, Malaterre J, Davenport AJ, Carpinteri S, Anderson RL, Darcy PK, et al. Therapeutic DNA vaccination against colorectal cancer by targeting the MYB oncoprotein. Clin Transl Immunol 2015; 4: e30.
12. Moskaluk CA, Baras AS, Mancuso SA, Fan H, Davidson RJ, Dirks DC, et al. Development and characterization of xenograft model systems for adenoid cystic carcinoma. Lab Invest 2011; 91: 1480-90.